Competitive Landscape: Leading Companies and New Entrants in the MicroRNA Market

The microRNA market is on the verge of significant expansion as advancements in molecular biology and diagnostics gain momentum. With increasing applications in personalized medicine and infectious disease research, the sector is poised for rapid development. Below, we explore the market's size projections, key players, emerging trends, and important segments shaping its future.

Anticipated Market Growth and Valuation of the MicroRNA Market by 2030
The microRNA market is predicted to experience swift growth over the coming years, reaching a valuation of $3.32 billion by 2030. This translates to a robust compound annual growth rate (CAGR) of 15.6%. Factors contributing to this growth include the rising use of microRNA diagnostics in clinical practice, expanded adoption of personalized medicine, ongoing development of therapeutic microRNA products, increased research in infectious diseases, and growing investments in molecular assay technologies. Key trends expected to influence the market during this time are the advancement of precision genomics, AI-driven microRNA expression analysis, the rise of cloud-based sequencing data storage solutions, automation within molecular diagnostics, and the incorporation of IoT-enabled laboratory workflow integration.

Download a free report of the microrna market report:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Leading Companies Influencing the MicroRNA Market Landscape
Several prominent organizations are shaping the microRNA market, including Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Miltenyi Biotec, LGC Limited, Promega Corporation, Abcam plc, Integrated DNA Technologies Inc., NanoString Technologies Inc., Horizon Discovery Ltd., OriGene Technologies Inc., Omega Bio-Tek, New England Biolabs, Quantabio, SeqMatic LLC, GeneCopoeia Inc., and HTG Molecular Diagnostics Inc.
In a significant development in May 2024, Bruker Corporation, a US-based scientific instruments firm, acquired NanoString Technologies Inc. for approximately $392.6 million. This acquisition aims to strengthen Bruker's expertise in gene expression profiling and spatial transcriptomics, bolstering its position in the life sciences research arena. NanoString Technologies, also US-based, specializes in solutions for gene expression analysis.

Current Trends Shaping Innovation in the MicroRNA Industry
Companies active in the microRNA space are increasingly integrating artificial intelligence (AI) to improve diagnostic precision and patient outcomes. AI's role in microRNA analysis helps optimize workflows and enhances the accuracy of test results. For example, in August 2023, Neurobit Inc., a US health analytics company, introduced Neurobit PSG, an AI-powered sleep scoring platform designed to revolutionize sleep analysis for healthcare providers, researchers, sleep laboratories, and enterprises. The platform delivers highly accurate sleep scoring using advanced AI algorithms while securely managing patient data within internal systems to ensure privacy and data protection.

View the full microrna market report:
https://www.thebusinessresearchcompany.com/report/microrna-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

The MicroRNA Market Segmentation and Key Application Areas
This market report divides the microRNA industry into several critical segments:
1) By Product Type: Instruments and Consumables
2) By Assay Type: Immunoassay, Next Generation Sequencing (NGS), microRNA Arrays, and PCR-Based Arrays
3) By Application: Cancer, Infectious Diseases, Immunological Disorders, Cardiovascular Disease, Neurological Disease, and Other Applications
4) By End User: Academic and Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, and Clinical Research Organizations

Further breakdown of subsegments includes:
- Instruments such as Quantitative PCR Systems, Microarray Platforms, Next-Generation Sequencing Systems, Real-Time PCR Instruments, and microRNA Analyzers
- Consumables including MicroRNA Kits (Extraction Kits, Detection Kits), PCR Reagents, Primers and Probes, Microarrays and Chips, and RNA Sequencing Kits

Through this detailed segmentation, the microRNA market's diverse components and applications become clear, highlighting its broad relevance across research and clinical fields.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.